SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-126600
Filing Date
2023-12-18
Accepted
2023-12-18 07:10:40
Documents
14
Period of Report
2023-12-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2333107d1_8k.htm   iXBRL 8-K 23623
2 EXHIBIT 99.1 tm2333107d1_ex99-1.htm EX-99.1 9988
6 GRAPHIC image_001.jpg GRAPHIC 3996
  Complete submission text file 0001104659-23-126600.txt   217818

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ckpt-20231215.xsd EX-101.SCH 3027
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ckpt-20231215_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ckpt-20231215_pre.xml EX-101.PRE 22367
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2333107d1_8k_htm.xml XML 3414
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38128 | Film No.: 231492229
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)